Literature DB >> 1944440

Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.

M Dreyfus1, J F Magny, F Bridey, H P Schwarz, C Planché, M Dehan, G Tchernia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1944440     DOI： 10.1056/NEJM199111283252207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns.

Authors:  Ryszard Lauterbach; Dorota Pawlik; Renata Radziszewska; Joanna Woźniak; Krzysztof Rytlewski
Journal:  Eur J Pediatr       Date:  2006-04-25       Impact factor: 3.183

Review 2.  Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism.

Authors:  U Nowak-Göttl; K Auberger; U Göbel; W Kreuz; R Schneppenheim; H Vielhaber; W Zenz; B Zieger
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

3.  Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.

Authors:  J Petäjä; J A Fernández; A Gruber; J H Griffin
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Authors:  David T Berg; Bruce Gerlitz; Jing Shang; Tommy Smith; Paula Santa; Mark A Richardson; Ken D Kurz; Brian W Grinnell; Ken Mace; Bryan E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

5.  Homozygous protein C deficiency presenting as neonatal purpura fulminans: management with fresh frozen plasma, low molecular weight heparin and protein C concentrate.

Authors:  Hande Kizilocak; Nihal Ozdemir; Gürcan Dikme; Begum Koc; Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

6.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin.

Authors:  R Drews; R K Paleyanda; T K Lee; R R Chang; A Rehemtulla; R J Kaufman; W N Drohan; H Luboń
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency.

Authors:  Sabine Kroiss; Manuela Albisetti
Journal:  Biologics       Date:  2010-03-24

8.  Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients.

Authors:  Alex Veldman; Doris Fischer; Flora Y Wong; Wolfhart Kreuz; Michael Sasse; Bruno Eberspächer; Ulrich Mansmann; Rudolf Schosser
Journal:  Crit Care       Date:  2010-08-19       Impact factor: 9.097

9.  Homozygous protein C deficiency--management with protein C concentrate.

Authors:  V Baliga; R Thwaites; M L Tillyer; A Minford; L Parapia; J Allgrove
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

10.  Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications.

Authors:  Paul N Knoebl
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.